Erlotinib
- Strength
- 100 mg/1
- Form
- Tablet, Film Coated
- Class
- Kinase Inhibitor
Teva Pharmaceuticals USA, Inc.
Erlotinib
Listed by Zydus Lifesciences Limited
- Strength
- 25 mg/1
- Form
- Tablet, Film Coated
- Route
- Oral
- Class
- Kinase Inhibitor
What it contains
- Erlotinib Hydrochloride 25 mg/1
FDA record
| Dosage form | Tablet, Film Coated |
|---|---|
| Route | Oral |
| Drug class | Kinase Inhibitor |
| Approval route | ANDA — approved generic |
| NDC code | 70771-1521 |
| FDA application | ANDA213065 |
| RxNorm concept | 603203 |
| Package sizes listed | 3 |
| Marketed since | April 2020 |
Other products containing Erlotinib
See allSame active ingredient, different manufacturer, strength or form. Products matching on both ingredient and strength are usually interchangeable — but confirm before switching, especially with modified-release forms.
Erlotinib
- Strength
- 100 mg/1
- Form
- Tablet, Film Coated
- Class
- Kinase Inhibitor
Aurobindo Pharma Limited
Erlotinib
- Strength
- 150 mg/1
- Form
- Tablet, Film Coated
- Class
- Kinase Inhibitor
Sun Pharmaceutical Industries, Inc.
Erlotinib
- Strength
- 150 mg/1
- Form
- Tablet, Film Coated
- Class
- Kinase Inhibitor
Zydus Lifesciences Limited
Erlotinib
- Strength
- 25 mg/1
- Form
- Tablet, Film Coated
- Class
- Kinase Inhibitor
Teva Pharmaceuticals USA, Inc.
ERLOTINIB
- Strength
- 25 mg/1
- Form
- Tablet, Film Coated
- Class
- Kinase Inhibitor
Camber Pharmaceuticals, Inc.
Erlotinib
- Strength
- 100 mg/1
- Form
- Tablet
- Class
- Kinase Inhibitor
Zydus Pharmaceuticals USA Inc.
ERLOTINIB
- Strength
- 100 mg/1
- Form
- Tablet, Film Coated
- Class
- Kinase Inhibitor
Camber Pharmaceuticals, Inc.
Information only, not medical advice. Nothing on this page indicates that a medication is safe or suitable for you. Speak to a prescriber or pharmacist before starting, stopping or switching any medicine.